| Financial Year |
March 31 2023 |
| Monetary Funds |
4,118,042,570.26 |
| Held-for-trading Financial Assets |
2,380,000,000.00 |
| Notes Receivable |
10,036,011.59 |
| Accounts Receivable |
9,851,403,667.84 |
| Advances to Suppliers |
288,588,327.04 |
| Other Receivables |
53,058,714.80 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
856,742,702.63 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
22,349,999.99 |
| Other Current Assets |
1,763,610.00 |
| Total Current Assets |
17,700,087,821.81 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
23,974,537,785.11 |
| Under-construction Projects |
2,336,939,651.85 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
1,942,437.56 |
| Oil and Gas Assets |
-- |
| Intangible Assets |
507,668,989.64 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
101,671,669.65 |
| Deferred Income Tax Assets |
229,253,594.28 |
| Other Non-Current Assets |
287,714,918.75 |
| Sub-Total of Non-Current Assets |
28,370,190,317.84 |
| Total Assets |
46,070,278,139.65 |
| Short-Term Loans |
300,238,333.34 |
| Trading Financial liabilities |
-- |
| Notes Payable |
616,311,982.97 |
| Accounts Payable |
1,994,893,045.70 |
| Accounts Received In Advance |
4,512,538.61 |
| Employee Compensation Payable |
2,333,609.03 |
| Taxes Payable |
150,139,003.15 |
| Interest Payable |
-- |
| Dividend Payable |
2,205,312.55 |
| Other payables |
257,002,566.17 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
3,628,741,470.82 |
| Other Current Liabilities |
27,698,128.04 |
| Sub-Total of Current Liabilities |
7,128,282,339.35 |
| Long-term Loans |
13,840,881,708.11 |
| Bonds Payable |
1,000,000,000.00 |
| Long-Term Accounts Payable |
515,468,731.05 |
| Special Payable |
-- |
| Estimatied Liabilities |
17,699,939.41 |
| Deferred Income Tax Liabilities |
159,321,778.05 |
| Other Non-Current Liabilities |
14,653,983.69 |
| Sub-Total of Non-Current Liabilities |
16,685,612,871.48 |
| Total Liabilities |
23,813,895,210.83 |
| Paid-In Capital(Or Share Stock) |
3,909,227,441.00 |
| Capital Surplus |
11,809,777,684.73 |
| Surplus Reserve |
282,874,277.52 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
6,214,503,136.08 |
| Minority Stockholder's Interest |
11,445,122.24 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
22,244,937,806.58 |
| Owner's Equity（Stockholder's Equity） |
22,256,382,928.82 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
46,070,278,139.65 |
